What is Hadassah Accelerator?

Hadassah Accelerator powered by IBM Alpha Zone is a 6 months program, helping startups build leading solutions for the medical global market. The program focuses on seed / post-seed startup companies, that aim to create outstanding solutions for medical needs and can benefit from long-term technology and business partnership with Hadassah hospital and IBM worldwide.

Benefits for Startups:

Access to Hadassah hospital clinical and research infrastructure ​

Access to IBM current solutions for medicine including the Watson and Watson Health solutions ​

Access to Hadassah hospital medical and expert professional staff ​

Endless Networking opportunities & guidance from top-notch mentors​

Global exposure and potential partnership with IBM worldwide​

Technology architecture design consulting and support​

Free office space at the BioHouse in Hadassah Ein Kerem​

Cloud services credit​

No equity is taken, and all IP you develop is yours​

The program is located on the premises of the BioHouse workspace in the Hadassah Ein Kerem Medical Center. It will provide companies with direct access to hospital resources, medical and professional staff. IBM will provide technological advice from its experts and access to its advanced technological tools, including hosting on IBM Cloud.

The Hadassah Accelerator is powered by IBM Alpha Zone Accelerator, which has been supporting and running a program with 63 graduates in 8 classes so far.

Areas of Focus

We are looking for solutions that can bring innovation to Healthcare, for startups focusing on digital technologies, that will include machine learning, AI, devices, applications, services and solutions, with the purpose of significantly improving diagnosis and treatment of patients worldwide.

Qualification criteria

The company is less than 5 years old (since establishment)​

Talented team
business and technological visionaries​


Strong technological fit with IBM solutions/technologies​

Registration to IBM Global Entrepreneur Program (Free)

The company is funded - seed or post seed​